NICE recommends advanced breast cancer treatment
The National Institute of Health and Care Excellence recommends the use of abemaciclib for breast cancer treatment.
It's for women with advanced breast cancer.
The combination treatment slows disease progression, and can delay the need for chemotherapy.
This guidance is due to be reviewed when final analysis of the MONARCH 2 study is available, expected to be February 2020.Published: by Radio NewsHub